Li Qi, Kaidong Liu, Tian Zhiyu, Diao Weihua, Sun Yuhong, Bai Ying, Ma Yueyue, Wei Yimiao, Li Jiarong, Zhao Weihong
Department of Obstetrics and Gynecology, The Second Hospital of Shanxi Medical University, Taiyuan, People's Republic of China.
The Second Clinical Medical College, Shanxi Medical University, Taiyuan, People's Republic of China.
J Inflamm Res. 2024 Nov 30;17:10119-10130. doi: 10.2147/JIR.S493854. eCollection 2024.
Persistent human papillomavirus infection is thought to be the main cause of the cervical cancer development along with inflammation. However, the potential mechanisms of action of the inflammatory factors in cervical cancer remain unclear. Therefore, this study aimed to assess the relationship between inflammatory factor levels and cervical cancer risk using a two-sample bidirectional Mendelian randomization (MR).
MR utilizes single nucleotide polymorphisms as a tool to infer potential causal relationships between exposure factors and outcomes. Datasets for 91 inflammatory factors and cervical cancer were obtained from publicly available pooled data. The inverse variance weighted method was used as the main method and MR-Egger, weighted median, simple mode, and weighted mode were used as auxiliary analyses. Results were tested for robustness using sensitivity tests. In addition, we assessed the possibility of reverse causality between cervical cancer and the derived inflammatory factors by performing a reverse MR analysis. Finally, a preliminary experimental validation was performed.
We found that artemin and monocyte chemoattractant protein-4 levels were significantly correlated with elevated cervical cancer risk (β: 0.0024, P = 0.002 and β: 0.0010, P = 0.016, respectively. In contrast, interleukin-18 and interleukin-22 receptor subunit alpha-1 levels were associated with reduced risk of cervical cancer (β: -0.0010, P = 0.029 and β: -0.0021, P = 0.046, respectively). Sensitivity analyses were more robust as no significant heterogeneity or horizontal pleiotropy was observed.
A significant causal relationship was found between the four inflammatory factors and the risk of cervical cancer, providing new evidence of their clinical implications in cervical cancer diagnosis and treatment.
持续性人乳头瘤病毒感染被认为是宫颈癌发生的主要原因,炎症也是其原因之一。然而,炎症因子在宫颈癌中的潜在作用机制仍不清楚。因此,本研究旨在使用两样本双向孟德尔随机化(MR)评估炎症因子水平与宫颈癌风险之间的关系。
MR利用单核苷酸多态性作为工具来推断暴露因素与结局之间的潜在因果关系。从公开可用的汇总数据中获取了91种炎症因子和宫颈癌的数据集。采用逆方差加权法作为主要方法,MR-Egger法、加权中位数法、简单模式法和加权模式法作为辅助分析。使用敏感性检验对结果进行稳健性检验。此外,我们通过进行反向MR分析评估了宫颈癌与衍生的炎症因子之间反向因果关系的可能性。最后,进行了初步的实验验证。
我们发现嗜铬粒蛋白A和单核细胞趋化蛋白4水平与宫颈癌风险升高显著相关(β分别为0.0024,P = 0.002和β为0.0010,P = 0.016)。相反,白细胞介素18和白细胞介素22受体亚基α-1水平与宫颈癌风险降低相关(β分别为-0.0010,P = 0.029和β为-0.0021,P = 0.046)。敏感性分析更具稳健性,因为未观察到显著的异质性或水平多效性。
发现四种炎症因子与宫颈癌风险之间存在显著的因果关系,为它们在宫颈癌诊断和治疗中的临床意义提供了新证据。